117 related articles for article (PubMed ID: 10717932)
1. [Pharmacoeconomics in helicobacter pylori infection (lecture)].
Isakov VA; Ivanikov IO
Ter Arkh; 2000; 72(2):61-3. PubMed ID: 10717932
[No Abstract] [Full Text] [Related]
2. [Should Helicobacter pylori be eradicated in patients with functional dyspepsia?].
Elizalde I; Borda F
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 2():43-6. PubMed ID: 11968334
[No Abstract] [Full Text] [Related]
3. Pharmacoeconomics in HP-related diseases: more questions than answers.
Deltenre M; De Bruyne I; Jonas C; De Koster E
Acta Gastroenterol Belg; 1998; 61(3):352-6. PubMed ID: 9795472
[No Abstract] [Full Text] [Related]
4. [Farmacoeconomical estimation of efficiency of different schemes of eradication therapy of Helicobacter pylori infection in children].
Kashnikova SN; Shcherbakov PL; Kashnikov VV; Tatarinov PA; Shcherbakova MIu
Eksp Klin Gastroenterol; 2008; (7):111-8. PubMed ID: 19334454
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group.
Gut; 1997 Sep; 41 Suppl 2():S1-9. PubMed ID: 9404236
[No Abstract] [Full Text] [Related]
6. [Indication for the treatment of Helicobacter pylori infection].
Svestka T; Krechler T; Brůha R; Jablonská M
Cas Lek Cesk; 2004; 143(12):850-3. PubMed ID: 15730218
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacoeconomics in the therapy of peptic ulcer].
Tesar T; Foltán V; Huorka M
Ceska Slov Farm; 2002 Mar; 51(2):78-83. PubMed ID: 11928281
[TBL] [Abstract][Full Text] [Related]
8. Pharmacoeconomics--determination of the cost-effectiveness of Helicobacter pylori eradication.
Curtiss FR
J Manag Care Pharm; 2003; 9(5):451-2, 455-6. PubMed ID: 14613444
[No Abstract] [Full Text] [Related]
9. [Does Helicobacter pylori infection cause dyspepsia in the absence of ulcer?].
Gomollón F
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 2():21-4. PubMed ID: 11968330
[No Abstract] [Full Text] [Related]
10. Evolution of the management of Helicobacter pylori infection in general practice.
Tosetti C
Helicobacter; 2006 Jun; 11(3):208-10. PubMed ID: 16684269
[No Abstract] [Full Text] [Related]
11. [Helicobacter pylori].
Macipe Costa RM; Gimeno Feliu LA; Feja Solana T; Ruiz Ferrando E
Med Clin (Barc); 1996 Sep; 107(8):317. PubMed ID: 8965497
[No Abstract] [Full Text] [Related]
12. Helicobacter pylori and non-malignant diseases.
Furuta T; Delchier JC
Helicobacter; 2009 Sep; 14 Suppl 1():29-35. PubMed ID: 19712165
[TBL] [Abstract][Full Text] [Related]
13. Management strategies for duodenal ulcer in India in the helicobacter pylori era: an economic analysis.
Ghoshal UC; Das A
Natl Med J India; 2002; 15(3):140-4. PubMed ID: 12186326
[TBL] [Abstract][Full Text] [Related]
14. [The evoluation of the strategy and tactics of treatment of Helicobacter pylori-dependent diseases].
Tsimmerman IaS
Klin Med (Mosk); 2007; 85(8):9-14. PubMed ID: 17926482
[TBL] [Abstract][Full Text] [Related]
15. The health economics of Helicobacter pylori infection.
Moayyedi P
Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori and non-malignant diseases.
Shirin H; Leja M; Niv Y
Helicobacter; 2008 Oct; 13 Suppl 1():23-7. PubMed ID: 18783518
[TBL] [Abstract][Full Text] [Related]
17. [Should Helicobacter pylori infection be considered in the management of dyspeptic patients?].
De Korwin JD
Gastroenterol Clin Biol; 1999 Oct; 23(10 Pt 2):C79-94. PubMed ID: 10880917
[No Abstract] [Full Text] [Related]
18. Proton pump inhibitor therapy and Helicobacter pylori infection: a complicated relationship.
McColl K
Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):185-6. PubMed ID: 16930290
[No Abstract] [Full Text] [Related]
19. Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori.
Zaidi SF; Yamada K; Kadowaki M; Usmanghani K; Sugiyama T
J Ethnopharmacol; 2009 Jan; 121(2):286-91. PubMed ID: 19041711
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori and non-malignant diseases.
Kupcinskas L; Malfertheiner P
Helicobacter; 2005; 10 Suppl 1():26-33. PubMed ID: 16178968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
